Caterina Patti Selected Research

Caterina Patti Research Topics

Disease

11	Hodgkin Disease (Hodgkin's Disease) 02/2022 - 08/2007
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2021 - 07/2008
8	Lymphoma (Lymphomas) 02/2021 - 03/2011
6	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 06/2004
4	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2021 - 07/2003
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 06/2004
3	B-Cell Lymphoma (Lymphoma, B Cell) 11/2016 - 03/2011
2	Neoplasms (Cancer) 03/2018 - 03/2011
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Thrombocytopenia (Thrombopenia) 12/2018
1	Pathologic Complete Response 10/2018
1	Disease Progression 01/2018
1	Necrosis 12/2017
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 11/2017
1	Osteonecrosis (Kienbock's Disease) 05/2017
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2007
1	Residual Neoplasm 08/2007
1	Agranulocytosis (Granulocytopenia) 06/2004

Drug/Important Bio-Agent (IBA)

17	Rituximab (Mabthera)FDA Link 01/2022 - 07/2003
9	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 08/2007
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 06/2004
6	Vinblastine (Vinblastine Sulfate)FDA Link 11/2020 - 08/2007
6	Dacarbazine (DIC)FDA LinkGeneric 11/2020 - 08/2007
5	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 10/2007
5	Bleomycin (Blenoxane)FDA LinkGeneric 11/2020 - 08/2007
4	Prednisone (Sone)FDA LinkGeneric 01/2021 - 10/2007
4	Bendamustine Hydrochloride FDA Link 12/2018 - 07/2012
3	Brentuximab VedotinIBA 02/2022 - 10/2017
3	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2021 - 11/2015
3	Etoposide (VP 16)FDA LinkGeneric 02/2021 - 11/2015
2	Methotrexate (Mexate)FDA LinkGeneric 02/2021 - 11/2015
2	Lenalidomide (CC 5013)FDA Link 01/2019 - 01/2017
2	Deoxyglucose (2 Deoxy D glucose)IBA 03/2011 - 08/2007
1	obinutuzumabIBA 12/2022
1	Chlorambucil (Leukeran)FDA Link 12/2022
1	idelalisibIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	fms-Like Tyrosine Kinase 3IBA 01/2022
1	midostaurinIBA 01/2022
1	gilteritinibIBA 01/2022
1	FumaratesIBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 02/2021
1	Carmustine (FIVB)FDA Link 02/2021
1	Glucose (Dextrose)FDA LinkGeneric 02/2021
1	Ifosfamide FDA LinkGeneric 02/2021
1	Saline SolutionIBA 02/2021
1	SolutionsIBA 02/2021
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 02/2021
1	Mesna (Coenzyme M)FDA LinkGeneric 02/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	venetoclaxIBA 01/2021
1	liposomal doxorubicin (Doxil)FDA Link 12/2019
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2019
1	ibrutinibIBA 01/2019
1	PanobinostatIBA 12/2018
1	SuspensionsIBA 12/2018
1	coltuximab ravtansineIBA 01/2018
1	Immunoconjugates (Immunoconjugate)IBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2017
1	Biomarkers (Surrogate Marker)IBA 10/2016
1	AntimetabolitesIBA 11/2015
1	Dimethoate (Rogor)IBA 04/2008
1	Monoclonal AntibodiesIBA 04/2008
1	Alemtuzumab (Campath)FDA Link 10/2007
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2004
1	Mitoxantrone (Novantrone)FDA LinkGeneric 06/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2004
1	fludarabineIBA 06/2004
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2004

Therapy/Procedure

18	Drug Therapy (Chemotherapy) 11/2020 - 07/2003
5	Therapeutics 02/2021 - 08/2007
5	Radiotherapy 11/2020 - 08/2007
4	Stem Cell Transplantation 02/2022 - 11/2015
4	Immunotherapy 10/2021 - 01/2018
2	Drug Tapering 12/2018 - 01/2017
2	Autologous Transplantation 04/2008 - 07/2003
1	Salvage Therapy 02/2022
1	Intravenous Infusions 02/2021
1	Splenectomy 12/2018
1	Mastectomy (Mammectomy) 12/2017
1	BEACOPP protocol 05/2017
1	Aftercare (After-Treatment) 09/2016
1	VAP-cyclo protocol 10/2007